Abirakast – Abiraterone Acetate Tablets IP 500 mg

Abirakast Abiraterone acetate Tablets IP 500 mg is indicated for use in combination with prednisone for the treatment of men with metastatic castration-resistant prostate cancer and who have already received some prior chemotherapy containing docetaxel.

Abirakast – Abirakast – Abiraterone Acetate Tablets IP 500 mg
Manufactured by : Aprazer Healthcare Pvt.Ltd.
Brand Name : Abirakast

Marketed By – Aprazer Healthcare Pvt.Ltd.
Active Ingredients : Abiraterone Acetate
Strength : 500 mg
Form : Tablets
Packing : Pack of 60 Tablets
Package Type : Plastic Bottle